China · Artificial Intelligence (AI) startup
China · METiS Pharmaceuticals
METiS Pharmaceuticals is the world's first AI-driven drug formulation company.
Funding reportedLast round: Series C
What company datasets say METiS Pharmaceuticals raised
Funding, as reported
Reported in all336Min the source's currency
Rounds4
Last roundSeries C
Last round dateJun 2024
Investors listed15
On a portfolio page
Investors who name them
Each firm lists METiS Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Artificial Intelligence (AI) in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put METiS Pharmaceuticals in front of investors. Or tell us what we have wrong.